COMMUNIQUÉS West-GlobeNewswire

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
10/12/2025
Tom Equels, CEO of AIM ImmunoTech, discusses the unmet need and driving Ampligen forward in pancreatic cancer OCALA, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
10/12/2025
The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health outcomes ASHEVILLE, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Aeroflow [...]
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership
10/12/2025
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG ) ("the Company") today announced a comprehensive restructuring and change of control following the acquisition [...]
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
10/12/2025
MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri [...]
USOSM Surgeon Partners Gave 2,170+ Patients in Africa and Central America More Reasons to Smile through Medical Missions This Year
10/12/2025
IRVING, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- During the past 12 months, U.S. Oral Surgery Management ( USOSM ) surgeon partners and their teams provided free oral care to more than 2,170 patients in Tanzania, Belize [...]
4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology
10/12/2025
Physics-informed, deterministic biomarkers from routine H&E slides run natively on AMD EPYC™ CPUs — enabling reproducible AI-driven solution in clinical trials SUNNYVALE, Calif. and NEWTON, Mass., Dec. 10, 2025 ( [...]
Akira Botanicals Announces Farm-Direct, Compliant CBD Relief Oils and Salves as Federal Hemp Rules Shift
10/12/2025
Akira Botanicals highlights its seed-to-bottle production model and its Sleep Oil with CBN, Energy Oil with THCV, and Relief Salves as the hemp industry adapts to new federal requirements. Marshall, NC, Dec. 10, 2025 ( [...]
JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China
10/12/2025
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years. PPF is a rare lung condition, more life-threatening than many forms of cancer, [...]
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference
10/12/2025
EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved next-generation wound care products, is pleased to announce [...]
BlossomHill Therapeutics Announces $84 Million Financing to Accelerate Clinical-Stage Pipeline of Intelligently Designed Cancer Medicines Including First-in-class Macrocyclic OMNI-EGFR™ Inhibitor for NSCLC
10/12/2025
Proceeds to further advance clinical development of BH-30643, a first-in-class, macrocyclic, CNS-active, mutant-selective OMNI-EGFR TM inhibitor for EGFR-mutant NSCLC, and BH-30236, a novel macrocyclic CLK inhibitor [...]
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
10/12/2025
MediWound Reports New Clinical Data Demonstrating NexoBrid ® ’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries Prospective clinical data show NexoBrid ® removes embedded particles in [...]
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
10/12/2025
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a strategic clinical collaboration with Varian, a Siemens [...]
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
10/12/2025
$47.5 million Series A financing led by Samsara Biocapital and Lightstone Ventures to advance PsiThera’s growing pipeline, starting with multiple clinically validated TNF superfamily preclinical programs Biotech veteran [...]
BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
10/12/2025
Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our Veterans POMPANO BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company [...]
Microbix Launches New Products to Support H3N2 Flu Testing
10/12/2025
Test-Controls & Reference Materials for Labs & Test-Makers MISSISSAUGA, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, [...]
New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD
10/12/2025
New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a high-risk CKD population [...]
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
10/12/2025
Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology targets The agreement - OBT's second high-profile pharma collaboration [...]
Bioxodes lève 5,5 millions d'euros dans le cadre d'une extension de la Série A afin de poursuivre la préparation d’un essai pivot pour son candidat-médicament innovant dans le traitement de l'AVC
10/12/2025
Newton Biocapital entre au capital en tant que nouvel investisseur, importante participation des investisseurs historiques Lancement en 2027 d’un essai pivot de phase 2b portant sur BIOX-101 dans le traitement de l’AVC [...]
Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate
10/12/2025
Newton Biocapital enters as new investor, strong participation of existing investors Pivotal Phase 2b trial initiation in 2027 of BIOX-101 to treat intracerebral hemorrhage BIOX-101 may be commercialized as early as H2 [...]

Pages